- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05984706
What Difficulties Do Children and Adolescents Experience in Everyday Activities After a Traumatic Event? Focus Groups and Delphi Survey for the Development of a Questionnaire on PTSD-related Functional Impairment
March 6, 2025 updated by: Lasse Bartels, University Children's Hospital, Zurich
Post-traumatic Stress Disorder (PTSD) in children and adolescents is often associated with a myriad of significant impairments in daily functioning, including family relationships, school/work, leisure time activities, and social relationships.
While a majority of attention has been placed on definition and assessment of post-traumatic stress symptoms (PTSS), less emphasis has been placed on the effect of PTSS on related functional impairment in daily life.
The current assessment of PTSD-related functional impairment is conducted either with additional items inserted in PTSD measures that inquire about daily functioning or with the utilization of global functional impairment measures.
The former approach is usually based on face validity only and varies content-wise.
The latter approach often consists of scales that conflate symptoms with functioning, focus on impairment due to physical rather than mental health problems, and are not validated in trauma-exposed children and adolescents.
Furthermore, scales usually do not include sufficient age-specific adjustments for younger children.
Thus, the current assessment of PTSD-related functional impairment in children and adolescents demonstrates noteworthy shortcomings.
Despite the well-recognized debilitating effect of PTSD on daily functioning, no measure has yet been developed to assess PTSD-related functional impairment tailored to trauma-exposed children and adolescents based on the input from the target population and their caregivers.
The aim of this project is therefore to develop an instrument that assesses PTSD-related functional impairment in trauma-exposed children and adolescents (young children age 1-6 years (caregiver-report) as well as for older children and adolescents age 7-18 years (self- and caregiver-report)) by conducting focus groups and a Delphi survey.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zurich, Switzerland, 8832
- University-Children's Hospital Zurich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
- Children and adolescents (7-18years old) who experienced at least one traumatic event.
- Caregivers of children and adolescents (1-18 years old) who experienced at least one traumatic event.
- Clinical experts
Description
Inclusion Criteria:
The same inclusion criteria apply for the focus group discussions and for the Delphi process.
For children and adolescents:
- Children and adolescents, who experienced at least one PTE according to the DSM-5 definition of a traumatic event.
- The PTE(s) must have occurred after the fourth birthday.
- The PTE(s) must have occurred at least 1 month ago.
- Children and adolescents must be 7-18 years of age.
- Children and adolescents are either in trauma-focused treatment at the time of recruitment or they present with at least a moderate PTSS severity according to the Child and Adolescents Trauma Screen 2 (CATS-2) Self-report.
- Children and adolescents must have sufficient command of the German language, excluding a small group of 4-5 unaccompanied refugee adolescents who will also be included. This group will be assisted by an interpreter.
- The children and adolescents do not have any physical impairment due to injuries or somatic illnesses (self-assessment).
- The children and adolescents are not acute suicidal. The responsible psychotherapists or supervisors of the "Schlupfhuus" will provide information about it.
For caregivers:
- Caregivers of children and adolescents, who experienced at least one PTE according to the DSM-5 definition of a traumatic event.
- The PTE(s) must have occurred at least 1 month ago.
- The child or adolescent must be between 1-18 years of age.
- Children and adolescents are either in trauma-focused therapy at the time of recruitment or they present with at least a moderate PTSS severity according to the Child and Adolescents Trauma Screen 2 (CATS-2).
- Caregivers must have sufficient command of the German language.
- The children and adolescents do not have any physical impairment due to injuries or somatic illnesses (self-assessment).
- The children and adolescents are not acute suicidal. The responsible psychotherapists or supervisors of the "Schlupfhuus" will provide information about it.
For clinical experts:
- Clinician or researcher specialized in trauma and PTSD in children and adolescents.
- Clinical experts must have sufficient command of the English language.
Exclusion Criteria:
For children and adolescent participants:
- Children and Adolescents who have not experienced at least one PTE according to the DSM-5 definition of a traumatic event.
- The PTE(s) occurred before the fourth birthday.
- The PTE(s) occurred less than 1 month ago.
- Children and adolescents that are younger than 7 years old and older than 18 years old.
- Children and adolescents that are neither in trauma-focused therapy at the time of recruitment nor meet the CATS-2 score for moderate PTSS severity or higher.
- Children and adolescents that do not have sufficient command of the German language.
- Children and adolescents that have physical impairment due to injuries or somatic illnesses (self-assessment).
- Children and adolescents that are acute suicidal. The responsible psychotherapists or supervisors of the "Schlupfhuus" will provide information about it.
For caregivers:
- Caregivers of children or adolescents who have not experienced at least one PTE according to the DSM-5 definition of a traumatic event.
- The PTE(s) occurred less than 1 month ago.
- The child or adolescent is younger than 1 year old or older than 18 years old.
- The child or adolescent is neither in trauma-focused therapy at the time of recruitment nor meets the CATS-2 score for moderate PTSS severity or higher.
- Caregivers that do not have sufficient command of the German language.
- Children and adolescents that have physical impairment due to injuries or somatic illnesses (self-assessment).
- Children and adolescents that are acute suicidal. The responsible psychotherapists or supervisors of the "Schlupfhuus" will provide information about it.
For clinical experts:
- Clinical experts that don't work as clinician or as researcher specialized in trauma and PTSD in children and adolescents.
- Clinical experts that do not have sufficient command of the English language.
All the participants' informed consent must be obtained before any data is collected.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Trauma-exposed children and adolescents
Focus group and Delphi survey
|
1. Focus groups to identify relevant domains of PTSD-related functional impairment in trauma-exposed children and adolescents to ensure content validity.
2. Delphi Questionnaire evaluation of a list of domains of PTSD-related functional impairment in trauma-exposed children and adolescents (previously selected from based on a literature review and focus groups) on a Likert scale of 1 to 5 for their relevance
|
|
Caregivers of trauma-exposed children and adolescents
Focus group and Delphi survey
|
1. Focus groups to identify relevant domains of PTSD-related functional impairment in trauma-exposed children and adolescents to ensure content validity.
2. Delphi Questionnaire evaluation of a list of domains of PTSD-related functional impairment in trauma-exposed children and adolescents (previously selected from based on a literature review and focus groups) on a Likert scale of 1 to 5 for their relevance
|
|
Clinical experts
Delphi survey
|
1. Focus groups to identify relevant domains of PTSD-related functional impairment in trauma-exposed children and adolescents to ensure content validity.
2. Delphi Questionnaire evaluation of a list of domains of PTSD-related functional impairment in trauma-exposed children and adolescents (previously selected from based on a literature review and focus groups) on a Likert scale of 1 to 5 for their relevance
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
A set of relevant domains and corresponding difficulties within domains of functional impairment in trauma-exposed children and adolescents, identified in focus groups.
Time Frame: Oct23-Nov23
|
Relevant domains of PTSD-related functional impairment in trauma-exposed children and adolescents will be identified via focus groups.
Trauma-exposed children and adolescents and caregivers will participate in small focus groups.
|
Oct23-Nov23
|
|
A set of relevant domains and corresponding difficulties within domains of functional impairment in trauma-exposed children and adolescents, identified in a Delphi survey.
Time Frame: Nov23-Feb24
|
Based on the results of the focus group discussions, relevant domains of PTSD-related functional impairment in trauma-exposed children and adolescents will be identified via Delphi survey.
Trauma-exposed children and adolescents, caregivers and clinical experts will participate.
Due to the exploratory design, no pre-existig scale will be used.
Participants will be asked to assess the previously identified areas of PTSD-related functional impairment in children and adolescents based on their importance.
For each previously identified domain, a 5-point Likert scale will be used to indicate how important it is to include that domain in the questionnaire we are developing.The scale ranges from (1) not important to (5) very important.
High scores indicate that it is important to include a specific domain in the questionnaire.
If the importance of a domain is rated above 1, the importance of specific difficulties within that domain will then be assessed on the same 5-point Likert scale.
|
Nov23-Feb24
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 20, 2023
Primary Completion (Actual)
January 31, 2025
Study Completion (Actual)
February 28, 2025
Study Registration Dates
First Submitted
July 21, 2023
First Submitted That Met QC Criteria
August 7, 2023
First Posted (Actual)
August 9, 2023
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 6, 2025
Last Verified
December 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2023-01290
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PTSD
-
University of PittsburghCompletedPTSD | Non PTSDUnited States
-
Imperial College Healthcare NHS TrustImperial College LondonRecruiting
-
VA Office of Research and DevelopmentSan Diego Veterans Healthcare SystemCompleted
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Completed
-
VA Office of Research and DevelopmentCompleted
-
Oregon Health and Science UniversityNational Center for Advancing Translational Sciences (NCATS); Oregon Clinical...Terminated
-
Creighton UniversityCompleted
-
VA Eastern KansasTerminated
-
University of Wisconsin, MadisonCompleted
-
Wake Forest University Health SciencesWithdrawn
Clinical Trials on Focus groups and Delphi Questionnaire
-
University of KwaZuluCompleted
-
University of RochesterTerminated
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruitingSyringomyelia | Chiari MalformationFrance
-
Great Ormond Street Hospital for Children NHS Foundation...RecruitingChronic Kidney Diseases | Hyperphosphatemia | Chronic Kidney Disease-Mineral and Bone Disorder | Pediatric Kidney Disease | CKD-MBDUnited Kingdom
-
M.D. Anderson Cancer CenterCompleted
-
University Health Network, TorontoCompleted
-
M.D. Anderson Cancer CenterUnited States Department of DefenseCompletedCancer | Prostate CancerUnited States
-
Sandra BucciUniversity of Edinburgh; NHS Lothian; Manchester University NHS Foundation Trust and other collaboratorsCompletedChild Sexual Abuse, Confirmed, SequelaUnited Kingdom
-
Ohio State UniversityRecruitingConsensus DevelopmentUnited States
-
University of Southern CaliforniaEnrolling by invitationConsensus DevelopmentUnited States